Genitourinary Cancer
Key updates at ASCO GU 2024
In this podcast, we will discuss key insights from the 2024 ASCO Genitourinary (GU) Cancers Symposium held in San Francisco,…
Date: 9th February 2024
Highlights in bladder and prostate cancer at PROCSA/BLADDR 2023
In this podcast, we’ll be covering highlights from the PROCSA/BLADDR 2023 Meeting, which took place in Valencia, Spain, such as…
Date: 2nd February 2024
Key updates at ESMO Asia 2023
The recent European Society for Medical Oncology (ESMO) Asia 2023 Congress in Singapore, brought together key oncology experts to delve…
Date: 26th January 2024
Highlights in GU cancer at ESMO 2023
The European Society for Medical Oncology (ESMO) Congress 2023, which took place in Madrid, Spain, gathered internationally acclaimed experts to…
Date: 3rd November 2023
Targeted radionuclide therapy in prostate cancer
Prostate cancer stands as the most frequently detected malignant condition among men, ranking as the second primary contributor to cancer-linked…
Date: 11th August 2023
iwCAR-T Session II: Cell therapies in GU cancers
The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April 2023, and brought…
Date: 25th May 2023
Radiotherapy Highlights from ASCO GU 2023 with Sophia Kamran, Himanshu Nagar, and Neha Vapiwala
In this podcast, hear from GU cancer experts Sophia Kamran (Massachusetts General Hospital and Harvard Medical School, Boston, MA), Himanshu…
Date: 6th April 2023
Key Trials from ASCO GU 2023 with Scott Tagawa, Karie Runcie, and Tanya Dorff
In this episode, join GU cancer experts Scott Tagawa (Weill Cornell Medicine and New York Presbyterian, New York City, NY),…
Date: 24th March 2023
Key data and hot topics in prostate cancer at ASCO GU 2023
In this episode, we’ll be hearing from GU cancer experts about some of the biggest prostate cancer data presented at…
Date: 3rd March 2023
Hot Topics in Bladder Cancer at ASCO GU 2023
In this podcast, we dive deep into some of the most exciting advances in bladder cancer research that were presented…
Date: 24th February 2023
Updates in Immuno-Oncology from ITOC 2022
The Immunotherapy of Cancer Conference (ITOC) 2022 brought together experts in the field of immuno-oncology to hear the latest findings…
Date: 24th October 2022
Updates in Checkpoint Inhibitors for Kidney Cancer
The advent of immune checkpoint inhibitors as a distinct class of immunotherapy has made a large impact within the field…
Date: 12th August 2022
